162 related articles for article (PubMed ID: 19819969)
1. Accelerated cartilage resorption by chondroclasts during bone fracture healing in osteoprotegerin-deficient mice.
Ota N; Takaishi H; Kosaki N; Takito J; Yoda M; Tohmonda T; Kimura T; Okada Y; Yasuda H; Kawaguchi H; Matsumoto M; Chiba K; Ikegami H; Toyama Y
Endocrinology; 2009 Nov; 150(11):4823-34. PubMed ID: 19819969
[TBL] [Abstract][Full Text] [Related]
2. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.
Kon T; Cho TJ; Aizawa T; Yamazaki M; Nooh N; Graves D; Gerstenfeld LC; Einhorn TA
J Bone Miner Res; 2001 Jun; 16(6):1004-14. PubMed ID: 11393777
[TBL] [Abstract][Full Text] [Related]
3. Immunolocalization of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin (OPG) in Meckel's cartilage compared with developing endochondral bones in mice.
Sakakura Y; Tsuruga E; Irie K; Hosokawa Y; Nakamura H; Yajima T
J Anat; 2005 Oct; 207(4):325-37. PubMed ID: 16191162
[TBL] [Abstract][Full Text] [Related]
4. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
[TBL] [Abstract][Full Text] [Related]
5. Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption.
Gerstenfeld LC; Cho TJ; Kon T; Aizawa T; Tsay A; Fitch J; Barnes GL; Graves DT; Einhorn TA
J Bone Miner Res; 2003 Sep; 18(9):1584-92. PubMed ID: 12968667
[TBL] [Abstract][Full Text] [Related]
6. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T
Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921
[TBL] [Abstract][Full Text] [Related]
7. Nonsteroidal antiinflammatory drugs and prostaglandin E(2) modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis.
Moreno-Rubio J; Herrero-Beaumont G; Tardio L; Alvarez-Soria MA; Largo R
Arthritis Rheum; 2010 Feb; 62(2):478-88. PubMed ID: 20112374
[TBL] [Abstract][Full Text] [Related]
8. Histamine contributes to increased RANKL to osteoprotegerin ratio through altered nuclear receptor 4A activity in human chondrocytes.
Marzaioli V; McMorrow JP; Angerer H; Gilmore A; Crean D; Zocco D; Rooney P; Veale D; Fearon U; Gogarty M; McEvoy AN; Stradner MH; Murphy EP
Arthritis Rheum; 2012 Oct; 64(10):3290-301. PubMed ID: 22674155
[TBL] [Abstract][Full Text] [Related]
9. Effects of osteoprotegerin administration on osteoclast differentiation and trabecular bone structure in osteoprotegerin-deficient mice.
Yamazaki H; Sasaki T
J Electron Microsc (Tokyo); 2005 Oct; 54(5):467-77. PubMed ID: 16339792
[TBL] [Abstract][Full Text] [Related]
10. Changes in serum levels of receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, IL-6 and TNF-alpha in patients with a concomitant head injury and fracture.
Lee JS; Ryu CH; Moon NH; Kim SJ; Park SY; Suh KT
Arch Orthop Trauma Surg; 2009 May; 129(5):711-8. PubMed ID: 18427820
[TBL] [Abstract][Full Text] [Related]
11. Melatonin impairs fracture healing by suppressing RANKL-mediated bone remodeling.
Histing T; Anton C; Scheuer C; Garcia P; Holstein JH; Klein M; Matthys R; Pohlemann T; Menger MD
J Surg Res; 2012 Mar; 173(1):83-90. PubMed ID: 20888595
[TBL] [Abstract][Full Text] [Related]
12. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
13. Direct effects of osteoprotegerin on human bone cell metabolism.
Grundt A; Grafe IA; Liegibel U; Sommer U; Nawroth P; Kasperk C
Biochem Biophys Res Commun; 2009 Nov; 389(3):550-5. PubMed ID: 19748486
[TBL] [Abstract][Full Text] [Related]
14. Bax deficiency in mice increases cartilage production during fracture repair through a mechanism involving increased chondrocyte proliferation without changes in apoptosis.
Rundle CH; Wang X; Sheng MH; Wergedal JE; Lau KH; Mohan S
Bone; 2008 Nov; 43(5):880-8. PubMed ID: 18708175
[TBL] [Abstract][Full Text] [Related]
15. Osteoprotegerin-Knockout Mice Developed Early Onset Root Resorption.
Liu Y; Du H; Wang Y; Liu M; Deng S; Fan L; Zhang L; Sun Y; Zhang Q
J Endod; 2016 Oct; 42(10):1516-22. PubMed ID: 27663616
[TBL] [Abstract][Full Text] [Related]
16. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide regulates receptor activator of nuclear factor-kappaB ligand and osteoprotegerin expression in bone marrow stromal cells.
Fan X; Roy E; Zhu L; Murphy TC; Ackert-Bicknell C; Hart CM; Rosen C; Nanes MS; Rubin J
Endocrinology; 2004 Feb; 145(2):751-9. PubMed ID: 14563699
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of crude bone morphogenetic protein-induced new bone formation and normalization of endochondral ossification by bisphosphonate treatment in osteoprotegerin-deficient mice.
Tabuchi M; Miyazawa K; Kimura M; Maeda H; Kawai T; Kameyama Y; Goto S
Calcif Tissue Int; 2005 Oct; 77(4):239-49. PubMed ID: 16193235
[TBL] [Abstract][Full Text] [Related]
19. In vitro expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in cultured equine articular cells.
Byron CR; Barger AM; Stewart AA; Pondenis HC; Fan TM
Am J Vet Res; 2010 Jun; 71(6):615-22. PubMed ID: 20513175
[TBL] [Abstract][Full Text] [Related]
20. Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption.
Tunyogi-Csapo M; Kis-Toth K; Radacs M; Farkas B; Jacobs JJ; Finnegan A; Mikecz K; Glant TT
Arthritis Rheum; 2008 Aug; 58(8):2397-408. PubMed ID: 18668542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]